The 13thth World Stem Cell Summit www.worldstemcellsummit.com is taking place January 23-26, 2018 at the Hyatt Regency Miami. Produced by the nonprofit Regenerative Medicine Foundation (RMF), the event is the global ecosystem meeting for advanced therapies; fostering public understanding, promoting positive policy initiatives and collaborations.
|
|||
The World Stem Cell Summit will be co-located with the field’s premier industry partnering event, Phacilitate Leaders Forum, Cell & Gene Therapy World and Immunotherapy World.
In addition to compelling keynotes, plenary and focus sessions, the diverse four-day program includes expert lunch roundtables; a centrally located Expo packed with innovators in industry, academia and government; a poster forum showcasing science and policy research; the gala Stem Cell Action Awards Dinner http://regmedfoundation.org/awards/; as well as many exclusive networking and partnering opportunities.
RMF Executive Director Bernard Siegel, founder and co-chair of the Summit said, “We are proud to select Miami to be our host for the next World Stem Cell Summit. Miami is often referred to as the 'City of the Future' and in 2018 it will be the center of the stem cell universe. It’s the perfect venue for Summit attendees to gain knowledge, network and collect opportunities to advance their goals, in a superlative, cosmopolitan setting.”
ABOUT RMF Regenerative Medicine Foundation is dedicated to accelerating regenerative medicine to improve health and deliver cures. RMF pursues its mission by producing its flagship World Stem Cell Summit, honoring leaders through the Stem Cell Action Awards http://worldstemcellsummit.com/stem-cell-action-awards/, publishing the World Stem Cell Report and RegMed Newsletter, organizing educational initiatives such as the upcoming Regenerative Medicine Essentials Course http://www.wakehealth.edu/Research/WFIRM/RMEssentials/Regenerative-Medicine-Essentials.htm and fostering strategic collaborations.
For more information about RMF, visit www.regmedfoundation.org or contact Bernard Siegel directly at [email protected].
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/64ef8cd8-84a3-4130-8a8f-f1e020eaeba3
Bernard Siegel Regenerative Medicine Foundation 3058014928 [email protected]


HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies
JD.com Pledges 22 Billion Yuan Housing Support for Couriers as China’s Instant Retail Competition Heats Up
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Rio Tinto Signs Interim Agreement With Yinhawangka Aboriginal Group Over Pilbara Mining Operations
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 



